Dr Reddys Laboratories Share Price Today - Live Blog for May 29, 2025

Dr Reddys Laboratories Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,248.80. With the stock's PE at 18.3500 and the industry PE at 33.9408, investors are weighing their options.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.22% recently. As of now, this stock is actively trading at a current market price of ₹1,249.80 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd's stock price surged by 0.17%, reaching the current market value of ₹1,246.90 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd experienced a -0.14% downturn in its share price, and it's currently trading at ₹1,244.80. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Dr Reddys Laboratories Ltd experienced a -0.19% slump and is currently trading at ₹1,246.20. While the stock maintains a PE ratio of 18.3500, the industry PE is 33.9408, raising questions about valuation.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.03%, with its current market value per share resting at ₹1,248.25. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's shares experienced a 0.09% uptick, and they are currently valued at ₹1,248.60, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.09% increase. Presently, it is actively trading at ₹1,248.60.

Dr Reddys Laboratories Ltd witnessed a -0.04% drop in its share price and is currently trading at ₹1,247.05. With the stock's PE at 18.3500 and the industry PE at 33.9408, investors are weighing their options.

With a -0.01% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,247.90. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.3500, while the industry PE is 33.9408.

Dr Reddys Laboratories Ltd's share price has fallen by -0.11%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,248.70, and market participants are assessing the implications. The stock has a PE ratio of 18.3500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares experienced a 0.15% uptick, and they are currently valued at ₹1,249.85, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

After a -0.07% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,250.95. The stock has a PE ratio of 18.3500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.01% gain, with the share price now at ₹1,251.95. Notably, the stock's PE ratio stands at 18.3500, and its Return on Equity (ROE) is 16.8559%.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.23% increase and currently trading at ₹1,251.20 per share. Investors are taking notice of this upward momentum.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.06% gain, with the share price now at ₹1,248.85. Notably, the stock's PE ratio stands at 18.3500, and its Return on Equity (ROE) is 16.8559%.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.08% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,248.95 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.16% recently. As of now, this stock is actively trading at a current market price of ₹1,248.00 per share, attracting attention from investors.

Following a noteworthy 0.03% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,246.70. When it comes to valuation, this stock has a PE ratio of 18.3500, with the industry PE ratio at 33.9408.

Dr Reddys Laboratories Ltd's share price rallied by 0.23%, reaching the current market price of ₹1,246.30. This surge is indicative of the stock's recent positive performance.

With a -0.05% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,245.35. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.3500, while the industry PE is 33.9408.

With a -0.05% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,245.35. The stock is currently trading at a PE of 18.3500, while the industry PE is 33.9408, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's share price rallied by 0.17%, reaching the current market price of ₹1,246.65. This surge is indicative of the stock's recent positive performance.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.04%. At this moment, it's actively trading at ₹1,244.30, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.35%, reaching a current market price of ₹1,244.65. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.35% drop, and it's now trading at ₹1,244.65 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.